Showing results (41-50 of 222) with videos related to
Sort By:
Pageof 23
Current Oncology (Toronto, Ont.)|June 7, 2012
Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosisC Weinstock, R Bigenwald, T Hochman, et al.Henry Ford Hospital Medical Journal|January 1, 1989
Early detection of hereditary medullary thyroid cancer with polymorphic DNA probes. Groupe d'Etude des Tumeurs a CalcitonineS A Narod, H Sobol, I Schuffenecker, et al.Human Genetics|March 1, 1991
The gene for MEN 2A is tightly linked to the centromere of chromosome 10S A Narod, H Sobol, I Schuffenecker, et al.Clinical Genetics|July 18, 2013
Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutationK A Metcalfe, C Kim-Sing, P Ghadirian, et al.Journal of the National Cancer Institute|November 16, 1994
High frequency of germline p53 mutations in childhood adrenocortical cancerJ Wagner, C Portwine, K Rabin, et al.Clinical Genetics|July 28, 1999
Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family historyP N Tonin, A M Mes-Masson, S A Narod, et al.Journal of Medical Genetics|October 1, 1996
Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sitesF Durocher, P Tonin, D Shattuck-Eidens, et al.Medical and Pediatric Oncology|October 1, 1997
Excess of congenital abnormalities in French-Canadian children with neuroblastoma: a case series study from MontréalW D Foulkes, P N Buu, D Filiatrault, et al.Carcinogenesis|May 29, 2003
Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groupsH Jernström, T L Klug, D W Sepkovic, et al.Lancet (London, England)|March 19, 1994
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage ConsortiumD Ford, D F Easton, D T Bishop, et al.Pageof 23